1. The impact of PET on the management of lung cancer: the referring physician's perspective;Seltzer;J Nucl Med,2002
2. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma;Gambhir;J Nucl Med,1996
3. NCCN non-small-cell lung cancer practice guidelines. The national comprehensive cancer network;Ettinger;Oncology (Williston Park),1996
4. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study;Kalff;J Clin Oncol,2001
5. Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer;Takeuchi;Eur J Nucl Med Mol Imaging,2014